FIELD: biotechnology.
SUBSTANCE: novel cell line of breast cancer of human BrCCh4e possessing stable cultural and morphological characteristics. BrCCh4e cell line is stored in the Special collection of vertebrate cell cultures of the Russian collection of cell cultures under registration number RKKK(P) 799D. Said cell line is intended for investigating carcinogenesis and metastasis, testing activity of antitumour agents in vitro and in vivo.
EFFECT: invention provides extending the range of cell lines possessing tumorigenicity and metastasis, which can be used to test activity of new anticancer drugs, as well as to search for new potential therapeutic markers.
1 cl, 5 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT HUMAN BREAST CANCER CELL LINE BRCCH4E-134, EXPRESSING HUMAN PROSTATE-SPECIFIC MEMBRANE ANTIGEN | 2019 |
|
RU2726541C1 |
| STABLE HUMAN BREAST CANCER CARCINOMA CELL LINE SKBR-KAT | 2018 |
|
RU2709675C1 |
| HUMAN BLADDER CANCER CELL LINE 190 BICAN KAG | 2021 |
|
RU2779948C1 |
| SODIUM COBALT POLYGALACTURONATE WITH ANTITUMOR ACTIVITY | 2023 |
|
RU2794885C1 |
| HUMAN BLADDER CANCER CELL LINE 198 BLCAN RLA | 2019 |
|
RU2733230C1 |
| PHARMACEUTICAL FORMULATION FOR METASTASIS PREVENTION AND INCREASING OF TUMOUR SENSITISATION TO CHEMOTHERAPEUTIC AGENTS | 2007 |
|
RU2328282C1 |
| HUMAN BLADDER CANCER CELL LINE 587 BLCAN TVV | 2020 |
|
RU2742244C1 |
| RECOMBINANT TARGET TOXIN SPECIFIC TO HER2 RECEPTOR EXPRESSING CELLS | 2016 |
|
RU2627215C1 |
| METHOD OF INHIBITING RADIATION-INDUCED INCREASE IN HUMAN BREAST CANCER STEM CELLS | 2022 |
|
RU2800366C2 |
| METHOD OF REDUCING THE NUMBER OF STEM CELLS OF HUMAN BREAST ADENOCARCINOMA | 2022 |
|
RU2798550C2 |
